CLKTF yields 20000000.00% · PFE yields 6.13%● Live data
📍 CLKTF pulled ahead of the other in Year 1
Combined, CLKTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLKTF + PFE for your $10,000?
CalciTech Ltd. develops and commercializes synthetic calcium carbonate (SCC) in Europe. It produces SCC from waste lime and air polluting carbon dioxide. SCC is a white pigment that is used in various industrial applications, including paper, polymers, paints, foods, and pharmaceuticals. The company offers three SCC products targeting the paper industry, which comprise CalciLS, which is designed to maximize light scattering; CalciSG that is designed to provide a gloss coating for premium grade printing and writing papers; and CalciRG, a performance-enhancing additive targeted at the rotogravure market. It also provides CalciSP, a non-paper product targeted at the food, pharmaceutical, and cosmetics industries; and CalciRC, which is targeted at polymer applications, such as plastics, sealants, rubber, and adhesives. The company was formerly known as Kemgas Ltd. and changed its name to CalciTech Ltd. in July 2000 to reflect change in business to the production and sale of SCC. CalciTech Ltd. was founded in 1978 and is based in Geneva, Switzerland.
Full CLKTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.